tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gobind Singh, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).
Analyst Gobind Singh, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 23.33% that have a potential upside of 33.26% achieved within 127 days.
Gobind Singh’s has documented 33 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RPHM, Reneo Pharmaceuticals at 08-Sep-2023.
Analyst best performing recommendations are on EVLO (EVELO BIOSCIENCES).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 5/24/2021. The price target of $48 was fulfilled within 57 days with a profit of $12.69 (35.94%) receiving and performance score of 6.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2
$1.95 (3900.00%)
$80
1 years 3 months 28 days ago
(26-Jul-2023)
1/2 (50%)
$-5.88 (-74.62%)
83
Buy
$10
$9.96 (24900.00%)
$10
1 years 8 months 6 days ago
(17-Mar-2023)
2/2 (100%)
$4.82 (93.05%)
79
Buy
$5
$4.96 (12400.00%)
1 years 8 months 7 days ago
(16-Mar-2023)
1/1 (100%)
$-0.98 (-16.39%)
4
Buy
$280
1 years 9 months 22 days ago
(01-Feb-2023)
1/3 (33.33%)
$120.6 (75.66%)
6
Buy
$50
$49.95 (99900.00%)
$12
2 years 7 days ago
(16-Nov-2022)
3/4 (75%)
$4.2 (9.17%)
100
What Year was the first public recommendation made by Gobind Singh?
